Starling Oncology, Inc. Business Combination, Acquisition Related Costs
Starling Oncology, Inc. (STLN) reported Business Combination, Acquisition Related Costs of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2025-03-26
- Starling Oncology, Inc. business combination, acquisition related costs for the quarter ending 2023-12-31 was $2.00K, a 97.78% decline year-over-year.
- Starling Oncology, Inc. business combination, acquisition related costs for the quarter ending 2023-09-30 was $41.00K, a 75.30% decline year-over-year.
- Starling Oncology, Inc. business combination, acquisition related costs for the quarter ending 2023-06-30 was $55.00K, a 50.45% decline year-over-year.
- Starling Oncology, Inc. business combination, acquisition related costs for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. business combination, acquisition related costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Starling Oncology, Inc. business combination, acquisition related costs for fiscal 2023 was $114.00K, a 85.57% decline from fiscal 2022.
- Starling Oncology, Inc. business combination, acquisition related costs for fiscal 2022 was $790.00K, a 65.97% increase from fiscal 2021.
- Starling Oncology, Inc. business combination, acquisition related costs for fiscal 2021 was $476.00K.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 9 month as first filed | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-26 | ||||
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $43.00K derived: sum of 2 quarters · filed 2025-03-26 | $98.00K derived: sum of 3 quarters · filed 2025-03-26 | $114.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $41.00K 10-Q · filed 2023-11-08 | $96.00K derived: sum of 2 quarters · filed 2023-11-08 | $112.00K 10-Q · filed 2023-11-08 | $186.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | $55.00K 10-Q · filed 2023-08-09 | $71.00K 10-Q · filed 2023-08-09 | $145.00K derived: sum of 3 quarters · filed 2024-03-28 | $311.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $90.00K derived: sum of 2 quarters · filed 2024-03-28 | $256.00K derived: sum of 3 quarters · filed 2024-03-28 | $367.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $256.00K derived: sum of 2 quarters · filed 2024-03-28 | $367.00K derived: sum of 3 quarters · filed 2024-03-28 | $790.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $166.00K 10-Q · filed 2023-11-08 | $277.00K derived: sum of 2 quarters · filed 2023-11-08 | $700.00K 10-Q · filed 2023-11-08 | $699.00K 10-Q · filed 2022-11-09 | $561.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $111.00K 10-Q · filed 2023-08-09 | $533.00K 10-Q · filed 2023-08-09 | $395.00K derived: sum of 3 quarters · filed 2023-08-09 | $466.00K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $76.00K 10-Q · filed 2023-05-10 | $284.00K derived: sum of 2 quarters · filed 2023-05-10 | $355.00K derived: sum of 3 quarters · filed 2023-05-10 | $462.00K derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $279.00K derived: sum of 2 quarters · filed 2023-03-16 | $386.00K derived: sum of 3 quarters · filed 2023-03-16 | $476.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $71.00K 10-Q · filed 2022-11-09 | $178.00K derived: sum of 2 quarters · filed 2022-11-09 | $268.00K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $107.00K 10-Q · filed 2022-08-09 | $197.00K 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $76.00K 10-Q · filed 2022-05-10 |